Lifeward Ltd. Files 8-K
Ticker: LFWD · Form: 8-K · Filed: Mar 31, 2026 · CIK: 0001607962
| Field | Detail |
|---|---|
| Company | Lifeward LTD. (LFWD) |
| Form Type | 8-K |
| Filed Date | Mar 31, 2026 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
TL;DR
Lifeward Ltd. filed an 8-K on 3/31/26 for an event on 3/30/26. No details yet.
AI Summary
Lifeward Ltd. filed an 8-K on March 31, 2026, reporting other events as of March 30, 2026. The filing does not contain specific financial details or significant business updates beyond the reporting of an event.
Why It Matters
This filing indicates a reportable event occurred for Lifeward Ltd. on March 30, 2026, requiring disclosure to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting an event without immediate disclosed financial impact or significant operational changes.
Key Players & Entities
- Lifeward Ltd. (company) — Filer of the 8-K report
- 0001607962 (company) — CIK number for Lifeward Ltd.
- 2026-03-31 (date) — Filing date of the 8-K
- 2026-03-30 (date) — Period of report for the 8-K event
FAQ
What specific event is Lifeward Ltd. reporting on March 30, 2026?
The filing does not specify the nature of the event, only that it occurred on March 30, 2026, and is being reported under Item 8.01 (Other Events).
When was this 8-K filing accepted by the SEC?
The 8-K filing was accepted on March 31, 2026, at 08:30:44.
What is Lifeward Ltd.'s CIK number?
Lifeward Ltd.'s CIK number is 0001607962.
What is Lifeward Ltd.'s primary business as indicated by its SIC code?
Lifeward Ltd.'s SIC code is 3842, which corresponds to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Does this filing provide any financial figures or dollar amounts?
No, this 8-K filing, under Item 8.01, does not provide any specific financial figures or dollar amounts.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2026-03-31 08:30:44
Filing Documents
- zk2634999.htm (8-K) — 49KB
- 0001178913-26-001944.txt ( ) — 175KB
- rwlk-20260330.xsd (EX-101.SCH) — 4KB
- rwlk-20260330_lab.xml (EX-101.LAB) — 21KB
- rwlk-20260330_pre.xml (EX-101.PRE) — 16KB
- zk2634999_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. As previously disclosed, Lifeward Ltd. (the "Company") received written notice (the "Notice") from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market LLC (the "Staff") stating that the Company, as a result of the resignation of Hadar Levy from the Company's Board of Directors (the "Board") and its Audit Committee, no longer complied with Nasdaq Listing Rule 5605(c)(2)(A), which requires listed companies to have an audit committee of at least three members. The Notice also acknowledged that the Nasdaq Listing Rules provide a cure period in order for the Company to regain compliance until the earlier of the Company's next annual meeting of shareholders or February 24, 2027; provided, however, that if the Company's next annual meeting of shareholders is held before August 24, 2026, then the Company must evidence compliance no later than August 24, 2026. On March 30, 2026, the Company received written notice from the Staff acknowledging the appointment of Messrs. Moshe Rozenbaum, William Mark Sigsbee and Yehuda Reznick to the Audit Committee and stated that the Company is now in compliance with Nasdaq Listing Rule 5605(c)(2)(A) and the matter is now closed
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lifeward Ltd. Dated: M arch 31, 2026 By: /s/ Almog Adar Name: Almog Adar Title: Chief Financial Officer